Clinical Trial Update: Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluates combining anastrozole and palbociclib for metastatic HER2-negative breast cancer, with the study currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Palbociclib (palbociclib)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Female Breast Carcinoma, Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING